| |
Latest 10 SEC filings (by transaction date) for REGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 17/24 | May 17/24 | Schleifer Leonard S | Direct Ownership | Common Stock | S - Open market or private sale | -143 | $980.07 |
May 17/24 | May 17/24 | Schleifer Leonard S | Direct Ownership | Common Stock | S - Open market or private sale | -22,687 | $979.22 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -9,242 | $975.48 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -7,611 | $974.51 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -2,653 | $973.80 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -790 | $972.22 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -4,922 | $971.56 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -4,669 | $970.26 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -9,501 | $969.39 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -3,213 | $968.44 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for REGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -9,242 | $975.48 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -7,611 | $974.51 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -2,653 | $973.80 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -790 | $972.22 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -4,922 | $971.56 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -4,669 | $970.26 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -9,501 | $969.39 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -3,213 | $968.44 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -379 | $978.18 |
May 17/24 | May 16/24 | Yancopoulos George | Direct Ownership | Common Stock | S - Open market or private sale | -1,227 | $977.38 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Madrigal Pharmaceuticals (OQ:MDGL) |
Vertex Pharmaceuticals (OQ:VRTX) |